New World Medical gains EU market access for its flagship glaucoma portfolio following successful MDR certification, positioning the firm for international revenue growth.
New World Medical has successfully secured MDR certification for its key glaucoma product portfolio, including the Ahmed Glaucoma Valve, Ahmed ClearPath, and KDB GLIDE. This regulatory milestone is a critical catalyst as it grants the company formal authorization to market and distribute these devices within the European Union, directly facilitating international revenue expansion.
The Ahmed Glaucoma Valve (AGV), Ahmed ClearPath (ACP), and KDB GLIDE.
It enables New World Medical to commercially distribute these specific glaucoma devices within the European Union.
New World Medical has received EU Medical Device Regulation (MDR) certification for its Ahmed Glaucoma Valve, Ahmed ClearPath, and KDB GLIDE products. This regulatory milestone clears the path for commercial expansion across European markets, bolstering the company's mid-term growth outlook.
The certification confirms that the company's glaucoma devices meet stringent European safety and performance standards, allowing for legal commercial distribution within the EU.